Study #2019-0915
Use of Patient-Reported Outcomes in Understanding Symptomatic Adverse Events in Early-Phase Trials of Combination Treatments that Include Immune Checkpoint Inhibitors and Targeted Therapy
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Use of PROs in Combination Trials Which Include At Least One Immune Checkpoint Inhibitor
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Not applicable
Physician name:
Goldy George
Department:
Symptom Research
For general questions about clinical trials:
1-855-452-0428
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.